GovWire

Guidance: The Innovative Devices Access Pathway (IDAP)

⌂Back To Homepage Subscribe To RSS Feed

Medicines Healthcare Products Regulatory Agency
February 15
15:27 2024
Print This Article Share it With Friends

The Innovative Devices Access Pathway (IDAP) pilot is an initiative to bring new technologies and solutions to the National Health Service (NHS) to help with medical needs that are not currently being met.

The aim of IDAP is to enable and improve patient access to innovative and transformative medical devices by providing an integrated and enhanced regulatory and access pathway to developers. The aim of the pilot is to test the main elements of the pathway and to provide informative learning and feedback that helps to build the future IDAP.

The eight successful applicants whose products have been selected for the pilot will receive support at key stages of their product development journey from theIDAPpartners.

Published 19 September 2023
Last updated 15 February 2024 +show all updates

  1. Changed to add Avegen Ltd to paragraphs on MS app being developed

  2. Changed attachment to note MS app has been developed by King's College London instead of Developed by Avegen Ltd.

  3. The IDAP pilot phase, pilot application and patient and public involvement and engagement pages have all been updated following the selection of the eight successful applicants

  4. Updated to add that the IDAP Pilot is closed for applications.

  5. Applications for the Innovative Devices Access Programme (IDAP) pilot now closes 1 November 2023 and further technical advice for applying has been updated.

  6. Details on 'How to Apply' have been updated to state that the IDAP Pilot is now closed for applications.

  7. FAQs have been added throughout the IDAP guidance webpage.

  8. Added a section title 'IDAP governance and patient and public involvement' to the IDAP pilot phase webpage.

  9. First published.

 Latest Government News
  
© 2024 Copyright CliqTo Media Ltd. Registered in England, company number 7575287. Privacy Policy | Terms & Conditions | Copyright Notice
Contains public sector information licensed under the Open Government Licence v3.0.

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: